References
- Sandilands AJ, O’Shaughnessy KM. The functional significance of genetic variation within the β1-adrenoceptor. Br. J. Clin. Pharmacol.60, 235–243 (2005).
- Mason DA, Moore DJ, Green SA et al. A gain-of-function polymorphism in a G-protein coupling domain of the human β1-adrenergic receptor. J. Biol. Chem.274, 12670–12674 (1999).
- Metra M, Nodari S, Parrinello G et al. Marked improvement in left ventricular ejection fraction during long-term β-blockade in patients with chronic heart failure: clinical correlates and prognostic significance. Am. Heart J.145, 292–299 (2003).
- Van Campen LC, Visser LC, Visser CA. Ejection fraction improvement by β-blocker treatment in patients with heart failure: an analysis of studies published in the literature. J. Cardiovasc. Pharmacol.32(Suppl. 1), S31–S25 (1998).
- Terra SG, Pauly DF, Lee CR et al. β-adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure. Clin. Pharmacol. Ther.77, 127–137 (2005).
- Terra SG, Hamilton KK, Pauly DF et al. β1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to β-blocker therapy. Pharmacogenet. Genomics15, 227–234 (2005).
- White HL, de Boer RA, Maqbool A et al. An evaluation of the β-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study. Eur. J. Heart Failure5, 463–468 (2003).
- de Groote P, Helbecque N, Lamblin N et al. Association between β-1 and β-2 adrenergic receptor gene polymorphisms and the response to β-blockade in patients with stable congestive heart failure. Pharmacogenet. Genomics15, 137–142 (2005).
- Liggett SB, Mialet-Perez J, Thaneemit-Chen S et al. A polymorphism within a conserved β1-adrenergic receptor motif alters cardiac function and β-blocker response in human heart failure. Proc. Natl Acad. Sci. USA103, 11288–11293 (2006).
- Mialet Perez J, Rathz DA, Petrashevsskaya NN et al. β1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat. Med.9, 1300–1305 (2003).
- Rathz DA, Brown KM, Kramer LA et al. Amino acid 49 polymorphisms of the human β1-adrenergic receptor affect agonist-promoted trafficking. J. Cardiovasc. Pharmacol.39, 155–160 (2002).